-+ 0.00%
-+ 0.00%
-+ 0.00%

REGENXBIO SHARES DOWN 19.6% PREMARKET AFTER CO REPORTS DUCHENNE DRUG LATE-STAGE TRIAL DATA

Reuters·05/14/2026 12:30:25

Please log in to view news